UNSPSC 51152022: Cyclobenzaprine

This classification denotes a muscle relaxant with the molecular formula C20H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69O5WQQ5TI, chemically known as 10,11-dehydroamitriptyline but generally known as cyclobenzaprine, which bears US NIH Compound Identifier 2895. European Medicines Agency schedules Cyclobenzaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06849MIG.

UNSPSC 51152022 Cyclobenzaprine is a Commodity code that nominally covers a specific muscle-relaxant pharmaceutical, yet the recent state and local opportunity posted under this code shows a material mismatch: Seminole County, Florida solicited naloxone and safe drug deactivation systems—neither of which are cyclobenzaprine. State and local procurement databases occasionally tag opportunities with codes that do not align with the work being bought. The code shows little relevant recent activity under its actual scope.

Seminole County issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The response deadline was July 26, 2023. Bidders were required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, provide drug-free workplace certification and E-Verify compliance, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract carried an initial two-year term with a one-year renewal option and a three-month probationary period, with potential FEMA funding and associated federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations were noted. This appears to be the only recent state or local opportunity associated with the cyclobenzaprine code, and it does not represent cyclobenzaprine procurement. Firms pursuing actual cyclobenzaprine supply contracts with state and local health systems should verify coding against pharmaceutical-specific UNSPSC families or monitor issuing bodies directly rather than rely on this code.